Novo Nordisk A/S
NOVO-B
Rang in Aktien
#108
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Aktienkurs
$39.53
Marktkapitalisierung
$174.45B
Veränderung (1 Tag)
0.75%
Veränderung (1 Jahr)
-25.98%
Land
DK
Handel Novo Nordisk A/S (NOVO-B)
Kategorie
Healthcare
Aktien-Split-Historie für Novo Nordisk A/S (NOVO-B)
Die Aktie Novo Nordisk A/S (Symbol: NOVO-B) durchlief insgesamt 6 Aktiensplits.
Der letzte Aktiensplit fand am Sep 13, 2023 statt.
Eine NOVO-B-Aktie, die vor dem Jun 04, 1991 gekauft wurde, entspricht heute 207.2 NOVO-B-Aktien.
Der letzte Aktiensplit fand am Sep 13, 2023 statt.
Eine NOVO-B-Aktie, die vor dem Jun 04, 1991 gekauft wurde, entspricht heute 207.2 NOVO-B-Aktien.
Liste der Aktiensplits
| Jahr | Aktien-Split | Multiplikator | Kumulierter Multiplikator |
|---|---|---|---|
| 2023-09-13 | 2:1 | x2 | x207.2 |
| 2014-01-02 | 5:1 | x5 | x103.6 |
| 2007-12-03 | 2:1 | x2 | x20.72 |
| 2001-04-04 | 5:1 | x5 | x10.36 |
| 1997-01-02 | 2:1 | x2 | x2.072 |
| 1991-06-04 | 259:250 | x1.036 | x1.036 |
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
| Unternehmen | Anzahl der Aktiensplits | Kumulierter Multiplikator | Land |
|---|---|---|---|
| 4 | x15 |
US
|
|
| 7 | x432 |
US
|
|
| 0 | - |
US
|
|
| 7 | x226 |
US
|
|
| 2 | x10000 |
CH
|
